Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2013
12/25/2013EP2675791A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
12/25/2013EP2488514B1 Indole and azaindole modulators of the alpha 7 nachr
12/25/2013EP2468729B1 Novel indazole derivative
12/25/2013EP2391627B1 Bicyclic pyrazolo-heterocycles
12/25/2013EP2358703B1 Tetrasubstituted pyridazines hedgehog pathway antagonists
12/25/2013EP2344459B1 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as fxr modulators against dyslipidemia and related diseases
12/25/2013EP2163553B1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
12/25/2013CN103476769A Novel anti-cancer agents
12/25/2013CN103476768A 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/25/2013CN103476767A Heterocyclic compounds as PI3 kinase inhibitors
12/25/2013CN103476757A Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
12/25/2013CN103468246A Organic luminescent material containing 1,2,4-tolyltriazole as well as preparation method and electroluminescent appliance of organic luminescent material containing 1,2,4-tolyltriazole
12/25/2013CN103467457A Maleimide-1,2,3-triazole compound with antibacterial activity and preparation method of compound
12/25/2013CN103467456A 3,5-disubstituted indolone derivatives and their preparation method and use
12/25/2013CN103467450A Novel organic electroluminescent (EL) material and application thereof in devices
12/25/2013CN103467447A Novel organic electroluminescent (EL) material and application thereof in devices
12/25/2013CN103467394A Method for preparing 1, 2, 3-triazole compound
12/25/2013CN103467391A Diaryl methyl piperazine compounds containing saturated nitrogen heterocyclic amide and application thereof
12/25/2013CN103467385A Monocyclic heteroaryl compounds
12/25/2013CN102272120B Biologically active amides
12/25/2013CN102046596B Substituted cyclohexyldiamines
12/25/2013CN101784540B Alcohols containing imide moieties and reactive oligomers prepared therefrom
12/25/2013CN101743241B Pyridazinone derivates
12/24/2013US8614302 Modified carbocyanine dyes and their conjugates
12/24/2013US8614242 1-(heterocyclic carbonyl)-2-substituted pyrrolidines
12/24/2013US8614206 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
12/24/2013CA2714181C Ampk modulators
12/24/2013CA2617096C Macrocyclic inhibitors of hepatitis c virus
12/24/2013CA2565200C Raf modulators and methods of use
12/19/2013WO2013188724A1 Azetidine and piperidine compounds useful as pde10 inhibitors
12/19/2013WO2013188381A1 Pyridinone and pyridazinone derivatives
12/19/2013WO2013187896A1 Biscarbazole derivative host materials and green emitter for oled emissive region
12/19/2013WO2013187689A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
12/19/2013WO2013187503A1 Glycine transporter inhibitor
12/19/2013WO2013187496A1 Aromatic heterocyclic compound
12/19/2013WO2013187466A1 Branched chain alkyl heteroaromatic ring derivative
12/19/2013WO2013186692A1 TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
12/19/2013WO2013186335A1 1,3 -dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
12/19/2013WO2013186333A1 1,3 -dihydro- 2h-benzimidazol- 2 -one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
12/19/2013US20130338371 Method for producing aromatic compound having ring structure that includes nitrogen atom or oxygen atom
12/19/2013US20130338179 Diaminopyrimidine derivatives and processes for the preparation thereof
12/19/2013US20130338167 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety
12/19/2013US20130338161 Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
12/19/2013US20130338159 Bi-heteroaryl compounds as vps34 inhibitors
12/19/2013US20130338158 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
12/19/2013US20130338155 Method for treating infections
12/19/2013US20130338154 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
12/19/2013US20130338147 4,6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/19/2013US20130338136 Novel indole modulators of s1p receptors
12/19/2013US20130338135 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
12/19/2013US20130338112 Compounds for the treatment of proliferative disorders
12/19/2013CA2876249A1 Branched chain alkyl heteroaromatic ring derivative
12/19/2013CA2875802A1 Azetidine and piperidine compounds useful as pde10 inhibitors
12/19/2013CA2875016A1 Pyridinone and pyridazinone derivatives
12/18/2013EP2674418A1 Biscarbazole derivative and organic electroluminescent element using same
12/18/2013EP2674417A2 Biaryl PDE4 inhibitors for treating inflammation
12/18/2013EP2673270A1 Insecticidal compounds
12/18/2013EP2673269A1 Heterocyclic compounds as pi3 kinase inhibitors
12/18/2013EP2673264A1 Microbiocidal pyrazole derivatives
12/18/2013EP2672819A1 Pesticidal compositions and processes related thereto
12/18/2013EP2481730B1 Insecticidal (1,3,5)-triazinyl phenyl hydrazones
12/18/2013EP2475650B1 Furan derivative and electrophotographic photoconductor
12/18/2013EP2426109B1 Novel kinase inhibitors
12/18/2013EP2398793B1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
12/18/2013EP2160388B1 Arylamide pyrimidone compounds
12/18/2013EP2150539B1 Pyridazinone derivatives
12/18/2013EP1616864B1 Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives
12/18/2013EP1276721B1 Methylation of indole compounds using dimethyl carbonate
12/18/2013CN103459551A Phototherapy devices and methods comprising optionally substituted terphenyl and quaterphenyl compounds
12/18/2013CN103459382A Heterocyclic compounds for the inhibition of pask
12/18/2013CN103459381A 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof
12/18/2013CN103459375A Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device
12/18/2013CN103450164A Geldanamycin derivatives as well as preparation methods and uses thereof
12/18/2013CN103450163A Indazole compounds, preparation method, and pharmaceutical applications thereof
12/18/2013CN103450162A Triazole alcohol compound containing benzamide structure and preparation method and application of triazole alcohol compound
12/18/2013CN103450092A Synthesis and preparation method of metronidazole-sulfanilamide derivatives
12/18/2013CN103450067A Bi[indole-3-yl-acetylamino acid] connected by ethyl, preparation method, antithrombotic function, and applications thereof
12/18/2013CN102712627B Process for preparation of pyrimidinylpyrazole compounds
12/18/2013CN102372675B 6-chlorine-4-iodine indazole, preparation method and application thereof
12/18/2013CN102307852B Cyclic amine compounds
12/18/2013CN102285971B Pyrazolyl quinazolinone compound and application thereof
12/18/2013CN102234266B Preparation and application of tetrahydrofolic acid ring-opened analogs with aziridine structure
12/18/2013CN102143958B Pyridazine derivatives as SMO inhibitors
12/18/2013CN101903374B 2-benzylpyridazinone derivatives as MET kinase inhibitors
12/18/2013CN101857589B Pyrazol-benzimidazoles derivative and application thereof
12/18/2013CN101679354B Triazinedione derivatives as GABAB receptor modulators
12/18/2013CN101621998B Benzimidazole cannabinoid agonists bearing substituted heterocyclic group
12/18/2013CN101489557B Co-crystals comprising VX-950 and pharmaceutical compositions comprising same
12/18/2013CN101410387B Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
12/18/2013CN101014587B Substituted biaryl piperazinyl-pyridine analogues
12/17/2013US8609860 Acid-labile trigger units
12/17/2013US8609859 One pot process for preparing 2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
12/17/2013US8609852 Thiazolyl mGluR5 antagonists and methods for their use
12/17/2013US8608907 Fluorescent whitening agent compositions
12/17/2013CA2733533C Hedgehog pathway modulators
12/17/2013CA2729495C Pyrimidine derivatives as kinase inhibitors
12/17/2013CA2615751C N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof
12/17/2013CA2527583C Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/12/2013WO2013184757A1 Compounds and compositions for modulating egfr activity
12/12/2013WO2013184702A1 Synthesis of antiviral compound
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 626